1. Home
  2. EQBK vs CTKB Comparison

EQBK vs CTKB Comparison

Compare EQBK & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EQBK
  • CTKB
  • Stock Information
  • Founded
  • EQBK 2002
  • CTKB 1990
  • Country
  • EQBK United States
  • CTKB United States
  • Employees
  • EQBK N/A
  • CTKB N/A
  • Industry
  • EQBK Major Banks
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • EQBK Finance
  • CTKB Health Care
  • Exchange
  • EQBK Nasdaq
  • CTKB Nasdaq
  • Market Cap
  • EQBK 763.9M
  • CTKB 718.8M
  • IPO Year
  • EQBK 2015
  • CTKB 2021
  • Fundamental
  • Price
  • EQBK $42.99
  • CTKB $5.12
  • Analyst Decision
  • EQBK Hold
  • CTKB Strong Buy
  • Analyst Count
  • EQBK 5
  • CTKB 2
  • Target Price
  • EQBK $45.60
  • CTKB $9.25
  • AVG Volume (30 Days)
  • EQBK 64.1K
  • CTKB 747.0K
  • Earning Date
  • EQBK 04-15-2025
  • CTKB 02-27-2025
  • Dividend Yield
  • EQBK 1.37%
  • CTKB N/A
  • EPS Growth
  • EQBK 700.00
  • CTKB N/A
  • EPS
  • EQBK 4.00
  • CTKB N/A
  • Revenue
  • EQBK $220,307,000.00
  • CTKB $201,210,000.00
  • Revenue This Year
  • EQBK N/A
  • CTKB $7.26
  • Revenue Next Year
  • EQBK $6.39
  • CTKB $8.20
  • P/E Ratio
  • EQBK $10.89
  • CTKB N/A
  • Revenue Growth
  • EQBK 59.51
  • CTKB 9.88
  • 52 Week Low
  • EQBK $30.44
  • CTKB $4.66
  • 52 Week High
  • EQBK $50.85
  • CTKB $9.33
  • Technical
  • Relative Strength Index (RSI)
  • EQBK 45.18
  • CTKB 37.48
  • Support Level
  • EQBK $43.01
  • CTKB $5.18
  • Resistance Level
  • EQBK $44.03
  • CTKB $5.48
  • Average True Range (ATR)
  • EQBK 0.96
  • CTKB 0.27
  • MACD
  • EQBK -0.07
  • CTKB 0.01
  • Stochastic Oscillator
  • EQBK 31.97
  • CTKB 27.85

About EQBK Equity Bancshares Inc.

Equity Bancshares Inc is a bank holding company. The company's operation involves the delivery of loan and deposit products to customers. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: